SERES THERAPEUTICS INC's ticker is MCRB and the CUSIP is 81750R102. A total of 120 filers reported holding SERES THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.20 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $69,972 | -81.7% | 29,400 | -63.2% | 0.00% | – |
Q2 2023 | $382,400 | +70.4% | 79,833 | +101.7% | 0.00% | – |
Q1 2023 | $224,419 | -10.5% | 39,580 | -11.6% | 0.00% | – |
Q4 2022 | $250,818 | +5.8% | 44,789 | +34.7% | 0.00% | – |
Q1 2022 | $237,000 | -91.4% | 33,260 | -89.9% | 0.00% | – |
Q4 2021 | $2,756,000 | +85.5% | 330,787 | +55.0% | 0.00% | – |
Q3 2021 | $1,486,000 | -77.4% | 213,454 | -22.5% | 0.00% | -100.0% |
Q2 2021 | $6,568,000 | +39.6% | 275,410 | +20.5% | 0.00% | 0.0% |
Q1 2021 | $4,705,000 | +21.4% | 228,522 | +44.5% | 0.00% | 0.0% |
Q4 2020 | $3,875,000 | -3.9% | 158,135 | +11.0% | 0.00% | -33.3% |
Q3 2020 | $4,033,000 | +5830.9% | 142,435 | +894.2% | 0.00% | – |
Q2 2020 | $68,000 | +61.9% | 14,327 | +22.2% | 0.00% | – |
Q1 2020 | $42,000 | -78.8% | 11,722 | -79.6% | 0.00% | – |
Q4 2019 | $198,000 | -46.5% | 57,427 | -37.8% | 0.00% | -100.0% |
Q3 2019 | $370,000 | +0.3% | 92,348 | -19.5% | 0.00% | 0.0% |
Q2 2019 | $369,000 | – | 114,659 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Flagship Pioneering Inc. | 14,378,802 | $342,935,000 | 4.38% |
SILVERARC CAPITAL MANAGEMENT, LLC | 122,700 | $2,926,000 | 1.30% |
COMMODORE CAPITAL LP | 145,453 | $3,469,000 | 1.21% |
Asymmetry Capital Management, L.P. | 63,259 | $1,509,000 | 1.04% |
Opaleye Management Inc. | 250,000 | $5,963,000 | 0.99% |
Ikarian Capital, LLC | 500,000 | $11,924,000 | 0.96% |
HighVista Strategies LLC | 44,750 | $1,068,000 | 0.76% |
SILVERARC CAPITAL MANAGEMENT, LLC | 63,915 | $1,524,000 | 0.68% |
Altium Capital Management LP | 104,626 | $2,495,000 | 0.58% |
Integral Health Asset Management, LLC | 75,000 | $1,789,000 | 0.49% |